Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on GABA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116606216B reveals a high-yield gabapentin preparation method using cyclohexyl chloride, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN105367434A details isobutyraldehyde route for pregabalin. Ensures high purity and supply chain stability for global pharmaceutical manufacturing needs.
Novel hydrolysis method for high-purity gabapentin. Reduces toxic impurities and energy consumption. Ideal for pharma supply chains.
Novel patent CN105061234A offers high-purity pregabalin route. Reduces costs and improves supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN102382785A details a novel biocatalytic route for high-purity pregabalin intermediates. Discover cost-effective manufacturing and supply chain advantages.
Novel lipase mutant enables high-purity pregabalin intermediate production with improved activity and supply chain reliability for pharmaceutical manufacturing.
Patent CN105985292B enables mild asymmetric catalysis. Delivers high-purity pharmaceutical intermediates with substantial cost reduction and supply chain reliability.
Patent CN103626668A offers high-efficiency resolution for S-pregabalin. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN114686465A reveals a hydrolase method for (R)-3-(carbamoylmethyl)-5-methylhexanoic acid, offering green, high-yield production for reliable supply chains.
Novel ammonium sulfate process for 3-isobutylglutaric acid. Enhances purity and supply chain reliability for pregabalin intermediate production globally.
Patent CN113804805B details a green, solvent-free method for synthesizing Pregabalin Impurity II. This breakthrough ensures reliable quality control standards and reduces manufacturing costs for pharmaceutical intermediates.
Novel green synthesis of ethyl 2-acetyl-3-nitromethylene-5-methyl-hexanoate using recyclable DES solvent, offering high yield and cost efficiency.
Patent CN110803994B reveals a green DES-based route for pregabalin intermediates. Discover how this technology enables cost reduction in API manufacturing and reliable supply.
Patent CN110803993B reveals a green DES-based synthesis for pregabalin intermediates, offering high yields, recyclable solvents, and scalable mechanochemical processing for cost-effective manufacturing.
Patent CN104086439A offers green recovery for pregabalin intermediates reducing waste and cost for reliable pharmaceutical intermediates supplier partnerships.
Novel isovaleraldehyde route enhances purity and yield. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel vanadium-catalyzed route offers high purity pregabalin. Reduces steps and improves yield for reliable API intermediate supplier.
Patent CN108715881B reveals a dual-enzyme route for pregabalin intermediates. Achieve 99.5% e.e. and simplified processing for cost-effective API manufacturing.
Patent CN104193635A offers high-purity pregabalin synthesis via Hofmann degradation ensuring cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN110713440B details a novel silyl-protection route for Vigabatrin intermediates, offering superior purity and scalable manufacturing for global pharmaceutical supply chains.